source
- Mid-size pharma firms drive surge in biopharma M&A activityThe article notes that 2026 is shaping up as one of the busiest years for biopharma mergers and acquisitions on record. Unlike previous years dominated by large multinational companies, a broader…
- Prevention and personalized skin care highlighted as future direction for melanoma oncodermatologyDr. Beth McLellan, a dermatologist, emphasizes that preventing radiation-induced skin damage is becoming a central focus in melanoma care. She also points out the need for equitable access to scal…